Login / Signup

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination.

Anita van de MunckhofKatarzyna KrzywickaDiana Aguiar de SousaMayte Sánchez van KammenMirjam Rachel HeldnerKatarina JoodErik LindgrenTurgut TatlisumakJukka PutaalaJohanna A Kremer HovingaSaskia MiddeldorpMarcel LeviMarcel ArnoldJose M FerroJonathan M Coutinho
Published in: European journal of neurology (2021)
The reported mortality of CVST with thrombocytopenia after vaccination with adenoviral vector-based SARS-CoV-2 vaccines has significantly decreased over time, which may indicate a beneficial effect of earlier recognition and/or improved treatment on outcome after VITT.
Keyphrases
  • sars cov
  • cardiovascular events
  • respiratory syndrome coronavirus
  • risk factors
  • pulmonary embolism
  • subarachnoid hemorrhage
  • type diabetes
  • coronary artery disease
  • blood brain barrier